Salarius Pharmaceuticals Inc. buy melinda
Start price
12.06.17
/
50%
€51,442
Target price
21.06.17
€57,784
Performance (%)
14.25%
End price
21.06.17
€58,771
Summary
This prediction ended on 21.06.17 with a price of €58,771. The prediction had a final performance of 14.25%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0,61 % | 0,34 % | 12,06 % | 58,10 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % | 1,74 % | 84,36 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % | 27,39 % | 64,84 % |
| iShares S&P 500 | 0,54 % | -0,70 % | 1,91 % | 58,67 % |
Comments by melinda for this prediction
In the thread Flex Pharma Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
Stopped prediction by melinda for Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€49,892
15.04.17
15.04.17
€57,784
27.04.17
27.04.17
9.04%
27.04.17
27.04.17
